| 1 | succinate metabolic process (GO:0006105) | 8.35776543 |
| 2 | cytoplasmic mRNA processing body assembly (GO:0033962) | 7.82939912 |
| 3 | peptidyl-arginine omega-N-methylation (GO:0035247) | 6.85962548 |
| 4 | peptidyl-arginine N-methylation (GO:0035246) | 6.37488411 |
| 5 | peptidyl-arginine methylation (GO:0018216) | 6.37488411 |
| 6 | tricarboxylic acid cycle (GO:0006099) | 6.08534192 |
| 7 | positive regulation of mitochondrial fission (GO:0090141) | 5.91140983 |
| 8 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 5.90004899 |
| 9 | positive regulation of B cell differentiation (GO:0045579) | 5.79404423 |
| 10 | coenzyme catabolic process (GO:0009109) | 5.24135887 |
| 11 | spermatid development (GO:0007286) | 5.23211547 |
| 12 | histone arginine methylation (GO:0034969) | 5.12561430 |
| 13 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 5.05612734 |
| 14 | regulation of mitochondrial depolarization (GO:0051900) | 5.03452627 |
| 15 | male sex determination (GO:0030238) | 4.91348554 |
| 16 | mitotic cell cycle arrest (GO:0071850) | 4.89308786 |
| 17 | ADP metabolic process (GO:0046031) | 4.73333413 |
| 18 | positive regulation of growth hormone secretion (GO:0060124) | 4.71984532 |
| 19 | nerve growth factor signaling pathway (GO:0038180) | 4.58878255 |
| 20 | sulfation (GO:0051923) | 4.42916523 |
| 21 | regulation of phosphoprotein phosphatase activity (GO:0043666) | 4.40774539 |
| 22 | negative regulation of activin receptor signaling pathway (GO:0032926) | 4.31990747 |
| 23 | glomerular visceral epithelial cell development (GO:0072015) | 4.31719142 |
| 24 | fibroblast migration (GO:0010761) | 4.29992207 |
| 25 | positive regulation of catecholamine secretion (GO:0033605) | 4.28624906 |
| 26 | relaxation of smooth muscle (GO:0044557) | 4.27073279 |
| 27 | regulation of mitochondrial fission (GO:0090140) | 4.09382203 |
| 28 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.02397621 |
| 29 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.94962129 |
| 30 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.94962129 |
| 31 | cellular response to zinc ion (GO:0071294) | 3.83537371 |
| 32 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.83473871 |
| 33 | positive regulation of protein homooligomerization (GO:0032464) | 3.81748841 |
| 34 | peptidyl-arginine modification (GO:0018195) | 3.81148130 |
| 35 | regulation of phospholipase A2 activity (GO:0032429) | 3.79336294 |
| 36 | activation of protein kinase B activity (GO:0032148) | 3.77524564 |
| 37 | urinary tract smooth muscle contraction (GO:0014848) | 3.76196487 |
| 38 | glomerular epithelial cell development (GO:0072310) | 3.73106422 |
| 39 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.69294056 |
| 40 | negative regulation of cell aging (GO:0090344) | 3.61963767 |
| 41 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.59909445 |
| 42 | granulocyte differentiation (GO:0030851) | 3.58408965 |
| 43 | lung-associated mesenchyme development (GO:0060484) | 3.56342082 |
| 44 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.49968829 |
| 45 | negative regulation of DNA binding (GO:0043392) | 3.48217506 |
| 46 | mitochondrion degradation (GO:0000422) | 3.47107475 |
| 47 | regulation of protein homooligomerization (GO:0032462) | 3.46614607 |
| 48 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.42912519 |
| 49 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.42912519 |
| 50 | response to muscle activity (GO:0014850) | 3.41559527 |
| 51 | regulation of coenzyme metabolic process (GO:0051196) | 3.40087018 |
| 52 | regulation of cofactor metabolic process (GO:0051193) | 3.40087018 |
| 53 | peroxisome fission (GO:0016559) | 3.36512311 |
| 54 | oligosaccharide biosynthetic process (GO:0009312) | 3.28306983 |
| 55 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.27266933 |
| 56 | base-excision repair, AP site formation (GO:0006285) | 3.23690917 |
| 57 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.23027562 |
| 58 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.21253420 |
| 59 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.20645805 |
| 60 | protein K6-linked ubiquitination (GO:0085020) | 3.18730746 |
| 61 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.15607300 |
| 62 | DNA double-strand break processing (GO:0000729) | 3.07397006 |
| 63 | purine nucleoside diphosphate metabolic process (GO:0009135) | 3.06557841 |
| 64 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 3.06557841 |
| 65 | muscle cell cellular homeostasis (GO:0046716) | 3.05426425 |
| 66 | regulation of timing of cell differentiation (GO:0048505) | 3.05405583 |
| 67 | neuromuscular synaptic transmission (GO:0007274) | 3.01488499 |
| 68 | regulation of membrane depolarization (GO:0003254) | 3.00405099 |
| 69 | muscle organ morphogenesis (GO:0048644) | 2.99128920 |
| 70 | positive regulation of protein kinase C signaling (GO:0090037) | 2.98340156 |
| 71 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.95857982 |
| 72 | DNA integration (GO:0015074) | 2.95261907 |
| 73 | neuronal action potential (GO:0019228) | 2.94037863 |
| 74 | sex determination (GO:0007530) | 2.92196527 |
| 75 | motile cilium assembly (GO:0044458) | 2.91139161 |
| 76 | negative regulation of smooth muscle contraction (GO:0045986) | 2.88836002 |
| 77 | ER overload response (GO:0006983) | 2.88172720 |
| 78 | extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625) | 2.88024178 |
| 79 | methionine biosynthetic process (GO:0009086) | 2.85367945 |
| 80 | positive regulation of receptor internalization (GO:0002092) | 2.85262788 |
| 81 | nucleotide phosphorylation (GO:0046939) | 2.81755334 |
| 82 | positive regulation of phosphatase activity (GO:0010922) | 2.77534132 |
| 83 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.76359199 |
| 84 | cofactor catabolic process (GO:0051187) | 2.76305366 |
| 85 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.75908978 |
| 86 | AMP metabolic process (GO:0046033) | 2.75741574 |
| 87 | protein import into peroxisome matrix (GO:0016558) | 2.75193802 |
| 88 | omega-hydroxylase P450 pathway (GO:0097267) | 2.74633380 |
| 89 | embryonic digestive tract development (GO:0048566) | 2.72782814 |
| 90 | negative regulation of organelle assembly (GO:1902116) | 2.72762651 |
| 91 | negative regulation of lipase activity (GO:0060192) | 2.71626664 |
| 92 | regulation of autophagic vacuole assembly (GO:2000785) | 2.70916202 |
| 93 | regulation of development, heterochronic (GO:0040034) | 2.68851389 |
| 94 | positive regulation of icosanoid secretion (GO:0032305) | 2.68530475 |
| 95 | behavioral response to nicotine (GO:0035095) | 2.67490458 |
| 96 | peristalsis (GO:0030432) | 2.67472452 |
| 97 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.67344431 |
| 98 | regulation of B cell differentiation (GO:0045577) | 2.65879813 |
| 99 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.64580122 |
| 100 | diacylglycerol metabolic process (GO:0046339) | 2.64466526 |
PFN1P3 
